German Biochip Maker GeneScan Buys Stake in US Company | GenomeWeb

NEW YORK, April 11 – Biochip maker GeneScan of Freiburg Germany has acquired a minority stake in Oasis Biosciences of San Diego, Reuters reported Wednesday.

GeneScan, which paid $6 million for a “significant” holding in the company, also acquired the option to buy a majority stake in Oasis in one year’s time, Reuters said.

GeneScan acquired the stake in Oasis in order to gain a hold of its technology to improve the speed and reliability of biochips as it prepares to enter the pharmacogenomics sector.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.